D.E. Shaw & Co’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-77,776
Closed -$266K 4472
2025
Q4
$266K Buy
77,776
+1,293
+2% +$5.77K ﹤0.01% 4205
2025
Q3
$385K Buy
76,483
+25,409
+50% +$112K ﹤0.01% 3994
2025
Q2
$175K Buy
+51,074
New +$127K ﹤0.01% 4070
2024
Q4
Sell
-420,240
Closed -$1.09M 4350
2024
Q3
$1.09M Sell
420,240
-46,325
-10% -$128K ﹤0.01% 3214
2024
Q2
$1.38M Buy
466,565
+13,330
+3% +$50.4K ﹤0.01% 2962
2024
Q1
$2.05M Buy
453,235
+422,602
+1,380% +$2.16M ﹤0.01% 2614
2023
Q4
$175K Sell
30,633
-404,720
-93% -$1.88M ﹤0.01% 3906
2023
Q3
$2M Sell
435,353
-77,450
-15% -$471K ﹤0.01% 2562
2023
Q2
$3.31M Sell
512,803
-955,593
-65% -$6.52M 0.01% 2213
2023
Q1
$11.1M Sell
1,468,396
-979,008
-40% -$8.89M 0.02% 1279
2022
Q4
$24.8M Sell
2,447,404
-327,955
-12% -$3.79M 0.04% 785
2022
Q3
$27.4M Buy
2,775,359
+1,672,839
+152% +$18.4M 0.05% 674
2022
Q2
$11.7M Buy
1,102,520
+1,073,423
+3,689% +$9.09M 0.02% 1254
2022
Q1
$284K Sell
29,097
-37,014
-56% -$350K ﹤0.01% 4678
2021
Q4
$945K Buy
66,111
+40,418
+157% +$613K ﹤0.01% 3975
2021
Q3
$515K Buy
+25,693
New +$454K ﹤0.01% 4072

Other funds holding ABCL